Differential atrial versus ventricular activities of class III potassium channel blockers

Journal of Pharmacology and Experimental Therapeutics

Volumn 285, Issue 1, 1998, Pages 135-142

  Baskin, Elizabeth P ^a   Lynch Jr , Joseph J ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 [2 (6 METHYL 2 PYRIDYL)ETHYL] 4 (4 METHYLSULFONYLAMINOBENZOYL)PIPERIDINE; AZIMILIDE; DOFETILIDE; IBUTILIDE FUMARATE; INDAPAMIDE; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; SOTALOL; TEDISAMIL; TERIKALANT;

ANTIARRHYTHMIC ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; DRUG SELECTIVITY; FERRET; HEART ATRIUM ARRHYTHMIA; HEART PAPILLARY MUSCLE; HEART VENTRICLE ARRHYTHMIA; NONHUMAN; PRIORITY JOURNAL; REFRACTORY PERIOD;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; ATRIAL FUNCTION; FERRETS; HEART; IMIDAZOLES; IMIDAZOLIDINES; MALE; PAPILLARY MUSCLES; PHENETHYLAMINES; PIPERAZINES; PIPERIDINES; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; PYRIDINES; SULFONAMIDES; TEMPERATURE; VENTRICULAR FUNCTION;

EID: 0031968731     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Amos GJ, Wettwer E, Metzger F, Li Q, Himmel HM and Ravens U (1996) Differences between outward currents of human atrial and subepicardial ventricular myocytes. J Physiol 491:31-50.
2. Baskin EP, Serik CM, Wallace AA, Brookes LM, Selnick HG, Claremon DA and Lynch JJ (1991) Effects of new and potent methanesulfonanilide Class III antiarrhythmic agents on myocardial refractoriness and contractility in isolated cardiac muscle. J Cardiovasc Pharmacol 18:406-414.
3. + currents in isolated human ventricular myocytes from patients with terminal heart failure. Circ Res 73:379-385.
4. Ks in guinea pig cardiac myocytes. Biochem Biophys Res Commun 202:265-270.
5. + current in cardiac myocytes by dofetilide. J Pharmacol Exp Ther 262:809-817.
6. + currents in mammalian cardiac and glial cells. J Pharmacol Exp Ther 254:560-569.
7. + current in rat ventricular myocytes. Am J Physiol 257:H1746-H1749.
8. Echt DS, Berte LE, Clusin WT, Samuelsson RG, Harrison DC and Mason JW (1982) Prolongation of the human cardiac monophasic action potential by sotalol. Am J Cardiol 50:1082-1086.
9. Echt DS, Lee JT, Murray KT, Vorperian V, Borganelli SM, Crawford DM, Friedrich T and Riden DM (1995) A randomized, double-blind, placebo-controlled doseranging study of dofetilide in patients with inducible sustained ventricular tachyarrhythmias. J Cardiovasc Electrophysiol 6:687-699.
10. Escande D, Coulombe A, Faivre J-F, Deroubaix E and Coraboeuf E (1987) Two types of transient outward currents in adult human atrial cells. Am J Physiol 252:H142-H148.
11. + current acting as pure Class III antiarrhythmic agents. J Cardiovasc Pharmacol 20:S106-S113.
12. Fermini B, Jurkiewicz NK, Jow B, Guinosso PJ, Baskin EP, Lynch JJ and Salata JJ (1995) Use-dependent effects of the Class III antiarrhythmic agent NE-10064 (azimilide) on cardiac repolarization: Block of delayed rectifier potassium and L-type calcium currents. J Cardiovasc Pharmacol 26:259-271.
13. Flaker GC, Blackshear JL, McBride R, Kronmal RA, Halperin JL and Hart RG for the SPAF Investigators (1992) Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. J Am Coll Cardiol 20:527-532.
14. Giles WR and Imaizumi Y (1988) Comparison of potassium currents in rabbit atrial and ventricular cells. J Physiol 405:123-145.
15. Hume JR and Uehara A (1985) Ionic basis of the different action potential configurations of single guinea pig atrial and ventricular myocytes. J Physiol 368:525-544.
16. Kr. Circulation 94:2938-2946.
17. + channel in human cardiac myocytes. Alterations in channel behavior in myocytes isolated from patients with idiopathic dilated cardiomyopathy. Circulation 92:164-174.
18. + current in guinea pig ventricular cells. J Pharmacol Exp Ther 262:99-108.
19. + current in human ventricular myocytes. Circ Res 78:689-696.
20. Mason JW for the ESVEM Investigators (1993) A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. JV Engl J Med 329:452-458.
21. Nabauer M, Beuckelmann DJ and Erdmann E (1993) Characteristics of transient outward current in human ventricular myocytes from patients with terminal heart failure. Circ Res 73:386-394.
22. Nair LA and Grant AO (1997) Emerging Class III antiarrhythmic agents: Mechanism of action and proarrhythmic potential. Cardiovasc Drugs Ther 11:149-167.
23. Ohler A, Amos GJ, Wettwer E and Ravens U (1994) Frequency-dependent effects of E-4031, almokalant, dofetilide and tedisamil on action potential duration. No evidence for "reverse use dependent" block. Naunyn-Schmiedebergs Arch Pharmacol 349:602-610.
24. Okada Y, Ogawa S, Sadanaga T and Mitamura H (1996) Assessment of reverse use-dependent blocking actions of Class III antiarrhythmic drugs by 24-hour Holter electrocardiography. J Am Coll Cardiol 27:84-89.
25. + current: differential sensitivity to block by Class III antiarrhythmic agents. J Gen Physiol 96:195-215.
26. Sedgwick ML, Dalrymple I, Rae AP and Cobbe SM (1995a) Effects of the new Class III antiarrhythmic drug dofetilide on the atrial and ventricular intracardiac monophasic action potential in patients with angina pectoris. Eur Heart J 16: 1641-1646.
27. Sedgwick ML, Lip G, Rae AP and Cobbe SM (1995b) Chemical conversion of atrial fibrillation with intravenous dofetilide. Int J Cardiol 49:159-166.
28. Stambler BS, Wood MA, Ellenbogen KA, Perry KT, Wakefield LK, VanderLugt JT and Ibutilde Repeat Dose Study Investigators (1996) Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Circulation 94:1613-1621.
29. Sung RJ, Tan HL, Karagounis L, Hanyok JJ, Falk R, Platia E, Das G, Hardy SA and the Sotalol Multicenter Study Group (1995) Intravenous sotalol for the termination of supraventricular tachycardia and atrial fibrillation and flutter: A multicenter, randomized, double double-blind placebo-controlled study. Am Heart J 129:739-748.
30. Thuringer D, Lauribe P and Escande D (1992) A hyperpolarization-activated inward current in human myocardial cells. J Mol Cell Cardiol 24:451-455.
31. Trautwein W, Kassebaum DG, Nelson RM and Hecht H (1962) Electrophysiological study of human heart muscle. Circ Res 10:306-312.
32. + current, by the diuretic agent indapamide in guinea pig myocytes. Circ Res 75:879-886.
33. Waldo AL, Camm AJ, deRuyter H, Friedman PL, MacNeil DJ, Pauls JF, Pitt B, Pratt CM, Schwartz PJ, Veltri EP for the SWORD Investigators (1996) Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. Lancet 348:7-12.
34. Wallace AA, Stupienski RF, Baskin EP, Appleby SD, Kothstein T, Gehret JR, King SW, Remy DC and Lynch JJ (1995) Cardiac electrophysiologic and antiarrhythmic actions of tedisamil. J Pharmacol Exp Ther 273:168-175.
35. Walsh KB and Kass RS (1988) Regulation of a heart potassium channel by protein kinase A and C. Science 242:67-69.
36. + current similar to Kv1.5 cloned channel currents. Circ Res 73:1061-1076.
37. Wang Z, Fermini B and Nattel S (1994) Rapid and slow components of delayed rectifier current in human atrial myocytes. Cardiovasc Res 28:1540-1546.
38. Kr) in AT-1 cells. Circulation 91:1799-1806.